(Q44061780)

29 November 2017

title

Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study (English)

1 reference

29 November 2017

0 references

1 reference

Henri-Jacques Delecluse

3

1 reference

29 November 2017

11

Marianne Wigger

1 reference

29 November 2017

Britta Höcker

1

1 reference

29 November 2017

Helmut Fickenscher

2

1 reference

29 November 2017

Stephan Böhm

4

1 reference

29 November 2017

Uta Küsters

5

1 reference

29 November 2017

Paul Schnitzler

6

1 reference

29 November 2017

Martin Pohl

7

1 reference

29 November 2017

Ulrike John

8

1 reference

29 November 2017

Markus J Kemper

9

1 reference

29 November 2017

Henry Fehrenbach

10

1 reference

29 November 2017

Martin Holder

12

1 reference

29 November 2017

Monika Schröder

13

1 reference

29 November 2017

Heiko Billing

14

1 reference

29 November 2017

Alexander Fichtner

15

1 reference

29 November 2017

Reinhard Feneberg

16

1 reference

29 November 2017

Anja Sander

17

1 reference

29 November 2017

Sabine Köpf-Shakib

18

1 reference

29 November 2017

Caner Süsal

19

1 reference

29 November 2017

Burkhard Tönshoff

20

1 reference

29 November 2017

language of work or name

English

0 references

publication date

5 October 2012

1 reference

Clinical Infectious Diseases

29 November 2017

published in

1 reference

29 November 2017

volume

56

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

84-92

1 reference

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epstein-Barr virus monitoring in paediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

New equations to estimate GFR in children with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epstein-Barr virus: evasive maneuvers in the development of PTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

EBV transformation overrides gene expression patterns of B cell differentiation stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epstein-Barr virus: exploiting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS823

21 January 2018

Identifiers

DOI

10.1093/CID/CIS823

1 reference

29 November 2017

1 reference